A Study of Carbon-14-Labelled [14C] LOXO-305 (Pirtobrutinib) in Healthy Male Participants
Clinical trial NCT06180954 · COMPLETED
Trial details
- NCT number
- NCT06180954
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-23
- Primary completion
- 2020-11-06
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.